15 results
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Vasculitis Management ... Algorithm - ACR ... #Vasculitis #Management ... #Treatment #ACR2021 ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Vasculitis Management ... Algorithm - ACR ... #Vasculitis #Management ... #Treatment #ACR2021 ... #rheumatology
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Management Algorithm ... - ACR/VF 2021 Guidelines ... immunosuppressive agent (e.g ... #Management #Treatment ... #rheumatology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
Vasculitis Management ... - ACR/VF 2021 Guidelines ... #Management #Treatment ... ACR2021 #Guidelines #algorithm ... #rheumatology
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology #treatment ... #medications #table ... #decisionaid #cardiology ... #hematology #warfarin
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Arteritis (GCA) - Vasculitis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... #Management #Treatment ... #rheumatology
Takayasu's Arteritis (TAK) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active TAK not on
Arteritis (TAK) - Vasculitis ... Management Algorithm ... - ACR/VF 2021 Guidelines ... #Management #Treatment ... #rheumatology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
erythematosus (ACLE ... vasculitis, rheumatoid ... Non-autoimmune rheumatologic ... activation and/or medications ... Erythematosus #Diagnosis #Rheumatology
Autoimmune Hepatitis

Clinical Presentation
 - Highly variable clinical presentation, from subclinical disease to acute liver failure.
 -
: Auto-Nuclear ANA ... Anti-LKM & Anti-ALC ... Viral) Management ... - Strong indications ... regarding need for treatment
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... Algorithm 1. ... current guidelines (eg ... controlled by above medications ... #Algorithm #cardiology